about
Disease monitoring in inflammatory bowel diseaseContribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel diseaseComparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children.JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease.Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel DiseaseThe Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel DiseaseDiagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain.Swimming attenuates inflammation, oxidative stress, and apoptosis in a rat model of dextran sulfate sodium-induced chronic colitis.Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue.Determinants of hypoxia inducible factor (HIF) activity in the intestinal mucosa.A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UCBiomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment.Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role.A systems pharmacology model for inflammatory bowel disease.Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.
P2860
Q26777553-4A84B84E-C192-491F-BD51-D3C0BF0C38CAQ27027429-ED7858AC-863B-4B2E-B2A4-7F75871FB041Q30275717-C6BF720F-2E98-47B1-9E84-C4E63CAB51B6Q33868659-8183B1EA-D47E-4713-9835-A2992E43480AQ36567001-5DD11A91-6B0B-459B-911B-387D800EAC4AQ37003637-F7F21504-12BA-43CD-AF03-487DE208963DQ37448575-2596860A-2BCD-479C-A683-8E08752DD891Q37702533-D6932F29-B7F7-4794-90C3-6E8FAAD31F51Q38621244-86DB7E97-3F12-479C-B1B6-583EF53B69AAQ39241653-9080672E-809D-4ACA-8A86-1580C04091E4Q39804119-5701CEB0-CCD1-4A0D-A480-9E1233C98CE3Q40739614-41032972-4098-48A4-9C0C-F654090FB734Q45898977-3F8376DE-5415-46E9-8218-FD32E6CDBAC9Q47107940-5A9F94E7-C263-44EA-BD43-75F170299A0BQ52364429-E528935D-D5BF-4416-B5C1-949498031959Q55501346-6C37EA77-2A20-4F5E-97A9-30C00B098CB3
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Biomarkers of inflammatory bowel disease.
@ast
Biomarkers of inflammatory bowel disease.
@en
type
label
Biomarkers of inflammatory bowel disease.
@ast
Biomarkers of inflammatory bowel disease.
@en
prefLabel
Biomarkers of inflammatory bowel disease.
@ast
Biomarkers of inflammatory bowel disease.
@en
P2860
P921
P356
P1433
P1476
Biomarkers of inflammatory bowel disease.
@en
P2093
Wu Jianbing
Yi Fengming
P2860
P304
P356
10.1155/2014/710915
P5008
P577
2014-05-19T00:00:00Z